Uebersax, J. S. (1988). Validity inferences from Interobserver agreement. Psychol Bull, 104(3), 405–416.
Article
Google Scholar
Uebersax, J. S. (1992). Modeling approaches for the analysis of observer agreement. Investig Radiol, 27(9), 738–743.
Article
CAS
Google Scholar
Uebersax, J. S. (1987). Diversity of decision-making models and the measurement of interrater agreement. Psychol Bull, 101(1), 140–146.
Article
Google Scholar
Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychol Bull, 86, 420–428.
Article
CAS
PubMed
Google Scholar
Atkinson, T. M., Li, Y., Coffey, C. W., Sit, L., Shaw, M., Lavene, D., Bennett, A. V., Fruscione, M., Rogak, L., Hay, J., Gonen, M., Schrag, D., & Basch, E. (2012). Reliability of adverse symptom event reporting by clinicians. Qual Life Res, 21(7), 1159–1164.
Article
PubMed
Google Scholar
Baldwin, P., Bernstein, J., & Wainer, H. (2009). Hip psychometrics. Stat Med, 28(17), 2277–2292.
Article
PubMed
Google Scholar
Linacre, J. M. (1991). Constructing measurement with a many-facet Rasch model.
Google Scholar
Atkinson, T. M., Rogak, L. J., Heon, N., Ryan, S. J., Shaw, M., Stark, L. P., Bennett, A. V., Basch, E., & Li, Y. (2017). Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting. J Cancer Res Clin Oncol, 143(4), 735–743.
Article
PubMed
PubMed Central
Google Scholar
Basch, E. (2010). The missing voice of patients in drug-safety reporting. N Engl J Med, 362(10), 865–869.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xiao, C., Polomano, R., & Bruner, D. W. (2013). Comparison between patient-reported and clinician-observed symptoms in oncology. Cancer Nurs, 36(6), E1–E16.
Article
PubMed
Google Scholar
Atkinson, T. M., Ryan, S. J., Bennett, A. V., Stover, A. M., Saracino, R. M., Rogak, L. J., Jewell, S. T., Matsoukas, K., Li, Y., & Basch, E. (2016). The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): A systematic review. Support Care Cancer, 24(8), 3669–3676.
Article
PubMed
PubMed Central
Google Scholar
Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006). Patient versus clinician symptom reporting using the National Cancer Institute common terminology criteria for adverse events: Results of a questionnaire-based study. Lancet Oncol, 7, 903–909.
Article
PubMed
Google Scholar
Basch, E., Jia, X., Heller, G., Barz, A., Sit, L., Fruscione, M., Appawu, M., Iasonos, A., Atkinson, T., Goldfarb, S., Culkin, A., Kris, M. G., & Schrag, D. (2009). Adverse symptom event reporting by patients vs clinicians: Relationships with clinical outcomes. J Natl Cancer Inst, 101(23), 1624–1632.
Article
PubMed
PubMed Central
Google Scholar
Bennett, B. K., Park, S. B., Lin, C. S., Friedlander, M. L., Kiernan, M. C., & Goldstein, D. (2012). Impact of oxaliplatin-induced neuropathy: A patient perspective. Support Care Cancer, 20(11), 2959–2967.
Article
PubMed
Google Scholar
Greimel, E. R., Bjelic-Radisic, V., Pfisterer, J., Hilpert, F., Daghofer, F., Pujade-Lauraine, E., & du Bois, A. (2011). Toxicity and quality of life outcomes in ovarian cancer patients participating in randomized controlled trials. Support Care Cancer, 19(9), 1421–1427.
Article
PubMed
Google Scholar
Neben-Wittich, M. A., Atherton, P. J., Schwartz, D. J., Sloan, J. A., Griffin, P. C., Deming, R. L., Anders, J. C., Loprinzi, C. L., Burger, K. N., Martenson, J. A., & Miller, R. C. (2011). Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a phase III trial of mometasone cream versus placebo during breast radiotherapy: The north central Cancer treatment group (N06C4). Int J Radiat Oncol Biol Phys, 81(2), 397–402.
Article
PubMed
Google Scholar
Dueck, A. C., Mendoza, T. R., Mitchell, S. A., Reeve, B. B., Castro, K. M., Rogak, L. J., Atkinson, T. M., Bennett, A. V., Denicoff, A. M., O'Mara, A. M., Li, Y., Clauser, S. B., Bryant, D. M., Bearden, J. D., 3rd, Gillis, T. A., Harness, J. K., Siegel, R. D., Paul, D. B., Cleeland, C. S., Schrag, D., Sloan, J. A., Abernethy, A. P., Bruner, D. W., Minasian, L. M., Basch, E., & National Cancer Institute, P. R. O. C. S. G. (2015). Validity and reliability of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). JAMA Oncol, 1(8), 1051–1059.
Article
PubMed
PubMed Central
Google Scholar
National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Published May 28, 2009; Revised Version 4.03 June 14, 2010. Available from: https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf [Accessed February 28, 2018].
Basch, E., Reeve, B. B., Mitchell, S. A., Clauser, S. B., Minasian, L. M., Dueck, A. C., Mendoza, T. R., Hay, J., Atkinson, T. M., Abernethy, A. P., Bruner, D. W., Cleeland, C. S., Sloan, J. A., Chilukuri, R., Baumgartner, P., Denicoff, A., St Germain, D., O'Mara, A. M., Chen, A., Kelaghan, J., Bennett, A. V., Sit, L., Rogak, L., Barz, A., Paul, D. B., & Schrag, D. (2014). Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst, 106(9).
Article
PubMed
PubMed Central
Google Scholar
Hay, J. L., Atkinson, T. M., Reeve, B. B., Mitchell, S. A., Mendoza, T. R., Willis, G., Minasian, L. M., Clauser, S. B., Denicoff, A., O'Mara, A., Chen, A., Bennett, A. V., Paul, D. B., Gagne, J., Rogak, L., Sit, L., Viswanath, V., Schrag, D., Basch, E., & Group, N. P.-C. S. (2014). Cognitive interviewing of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Qual Life Res, 23(1), 257–269.
Article
PubMed
Google Scholar
Mendoza, T. R., Dueck, A. C., Bennett, A. V., Mitchell, S. A., Reeve, B. B., Atkinson, T. M., Li, Y., Castro, K. M., Denicoff, A., Rogak, L. J., Piekarz, R. L., Cleeland, C. S., Sloan, J. A., Schrag, D., & Basch, E. (2017). Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE. Clin Trials, 14(3), 255–263.
Article
PubMed
PubMed Central
Google Scholar
Bennett, A. V., Dueck, A. C., Mitchell, S. A., Mendoza, T. R., Reeve, B. B., Atkinson, T. M., Castro, K. M., Denicoff, A., Rogak, L. J., Harness, J. K., Bearden, J. D., Bryant, D., Siegel, R. D., Schrag, D., Basch, E., & National Cancer Institute, P. R. O. C. S. G. (2016). Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Health Qual Life Outcomes, 14, 24.
Atkinson, T. M., Hay, J. L., Dueck, A. C., Mitchell, S. A., Mendoza, T. R., Rogak, L. J., Minasian, L. M., & Basch, E. (2017). What do "none," "mild," "moderate," "severe" and "very severe" mean to patients with cancer? Content validity of PRO-CTCAE response scales. J Pain Symptom Manage.
Mendoza, T. R., Dueck, A. C., Mitchell, S. A., Reeve, B. B., Li, Y., Atkinson, T. M., Bennett, A. V., Clauser, S. B., & Basch, E. (2012). The effect of skip patterns on the validity and reliability of selected items from the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Paper presented at the (p. 2012). San Diego, CA: Joint Statistical Meetings.
Google Scholar
Lord, F. M., & Novick, M. R. (1968). Statistical theories of mental test scores. Reading, MA: Addison Wesley.
Google Scholar
Bjorner, J. B., Chang, C. H., Thissen, D., & Reeve, B. B. (2007). Developing tailored instruments: Item banking and computerized adaptive assessment. Qual Life Res, 16(Suppl 1), 95–108.
Article
PubMed
Google Scholar
Simpson, D., Rue, H., Riebler, A., Martins, T. G., & Sørbye, S. H. (2017). Penalising model component complexity: A principled, practical approach to constructing priors. Stat Sci, 32(1), 1–28.
Article
Google Scholar
Development Core Team, R. (2017). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing Retrieved from http://www.R-project.org.
Google Scholar
Plummer, M. (2017). JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling: Retrieved from: http://mcmc-jags.sourceforge.net.
Curtis, S. M. (2010). BUGS code for item response theory. J Stat Softw, 36(1), 1–34.
Google Scholar
Drotar, D. (Ed.). (1998). Measuring health-related quality of life in children and adolescents: Implications for research and practice. Mahwah, NJ: Lawrence Erlbaum Associates, Inc..
Google Scholar
Preen, D. B., Holman, C. D., Lawrence, D. M., Baynham, N. J., & Semmens, J. B. (2004). Hospital chart review provided more accurate comorbidity information than data from a general practitioner survey or an administrative database. J Clin Epidemiol, 57(12), 1295–1304.
Article
PubMed
Google Scholar
Patrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K., Martin, M. L., Molsen, E., & Ring, L. (2011). Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 2-assessing respondent understanding. Value Health, 14(8), 978–988.
Article
PubMed
Google Scholar